Please Wait
Applying Filters...
menu
    • menu
    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    Valsynthese, part of the SSE Group, is a CDMO focused on highly energetic and highly hazardous chemistry.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    With Fermion, start the journey of your innovative API.

    Virtual Booth

    Contact Supplier

    Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    Crofelemer

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    PATENTS & EXCLUSIVITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 7,624Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Jaguar’s Crofelemer Show Positive Results For CTD In Breast Cancer
    Jaguar’s Crofelemer Show Positive Results For CTD In Breast Cancer

    12 Dec 2024

    // ACCESSWIRE

    https://www.accesswire.com/952069/significant-positive-results-with-jaguar-healths-crofelemer-for-cancer-therapy-related-diarrhea-ctd-in-breast-cancer-patients-presented-at-san-antonio-breast-cancer-symposium-sabcs

    ACCESSWIRE
    12 Dec 2024
    Share Share
    Jaguar Health Reports Positive Phase 3 Results For Crofelemer
    Jaguar Health Reports Positive Phase 3 Results For Crofelemer

    01 Oct 2024

    // ACCESSWIRE

    https://www.accesswire.com/925756/jaguar-health-reports-statistically-significant-improvement-in-breast-cancer-patients-in-its-phase-3-ontarget-trial-for-its-cancer-supportive-care-drug-crofelemer

    ACCESSWIRE
    01 Oct 2024
    Share Share
    Jaguar Health To Explore Crofelemer For Breast And Lung Cancer
    Jaguar Health To Explore Crofelemer For Breast And Lung Cancer

    05 Aug 2024

    // ACCESSWIRE

    https://www.accesswire.com/viewarticle.aspx?id=896292&lang=en

    ACCESSWIRE
    05 Aug 2024
    Share Share
    Jaguar Health To Report Phase 3 Crofelemer Results On July 23
    Jaguar Health To Report Phase 3 Crofelemer Results On July 23

    18 Jul 2024

    // ACCESSWIRE

    https://www.accesswire.com/viewarticle.aspx?id=889979&lang=en

    ACCESSWIRE
    18 Jul 2024
    Share Share
    Jaguar Health To Report Phase 3 OnTarget Trial Results By July 23
    Jaguar Health To Report Phase 3 OnTarget Trial Results By July 23

    12 Jun 2024

    // ACCESSWIRE

    https://www.accesswire.com/viewarticle.aspx?id=876430&lang=en

    ACCESSWIRE
    12 Jun 2024
    Share Share
    Jaguar Health: Positive Crofelemer Trial Results For Functional Diarrhea
    Jaguar Health: Positive Crofelemer Trial Results For Functional Diarrhea

    28 May 2024

    // ACCESSWIRE

    https://www.accesswire.com/867976/investigator-initiated-trial-of-jaguar-healths-crofelemer-yields-positive-results-for-functional-diarrhea

    ACCESSWIRE
    28 May 2024
    Share Share